ARS Pharmaceuticals, Inc. (SPRY)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
34
$240.06M held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| BlackRock, Inc. | Aug 7, 2026 | $42.54M |
| STATE STREET CORP | Aug 7, 2026 | $29.88M |
| FRANKLIN RESOURCES INC | May 13, 2026 | $26.33M |
| Capital World Investors | Aug 12, 2026 | $22.07M |
| Vanguard Capital Management | Aug 13, 2026 | $20.45M |
SPRY's filings are public. The insight is one click away.
Scrutar's AI reads every SPRY filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze SPRY filingsNo credit cardAI reports included on the free plan
Never miss a SPRY filing.
Get an email when SPRY files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 29, 2026Source: SEC EDGAR.